Search - tctmd.com

Displaying 121 - 140 of 155

Sort: Relevancy | Date

News Daily News

ISCHEMIA Patients: High Rates of Severe-to-Moderate Ischemia, Multivessel CAD

Michael O'Riordan

March 01, 2019

News Daily News

The Case for Collateralization: CABG’s Mechanism for Survival in Stable CAD Underappreciated by Patients

L.A. McKeown

February 26, 2019

News Daily News

FDA Approves Orsiro Ultrathin-Strut Stent for CAD

Michael O'Riordan

February 22, 2019

Podcast TCTMD Talking Points

BIONYX: A Thin Composite-Wire Strut, Durable Polymer-Based DES Compared With an Ultrathin-Strut Bioresorbable Polymer-Based DES in an All-Comers Patient Population

February 20, 2019

News Daily News

Mortality Data ‘Inadvertently Omitted’ From IN.PACT Analysis of Paclitaxel-Coated Balloons

L.A. McKeown

February 19, 2019

Presentation JIM 2019

Iatrogenic aortocoronary dissection after routine PCI

Presenter: Pamela Gatto

February 15, 2019

Presentation JIM 2019

Small Vessel PCI

Presenter: Nick Parchure

February 15, 2019

Presentation JIM 2019

Small Vessel Intervention - DES

Presenter: Anand Gnanaraj

February 15, 2019

Presentation JIM 2019

Treatment of Small Vessels Made Easy With Drug Eluting Balloon

Presenter: Col Anil Dhall

February 15, 2019

Presentation JIM 2019

12 months results of First-In-Man study with coronary dedicated bifurcation cobalt-chromium sirolimus-eluting stent BiOSS LimC

Presenter: Robert J. Gil

February 15, 2019

Presentation JIM 2019

Overall Experience of Abluminus DES in Real World and Dedicate Global Clinical Registry

Presenter: Luca Testa

February 14, 2019

Presentation JIM 2019

Cre8™ EVO: Turning PCI challenges of DM patients into today’s solution

Presenter: Didier Carrié

February 14, 2019

Presentation JIM 2019

Unmet Clinical Needs With Current Drug-Eluting Stents

Presenter: Davide Capodanno

February 14, 2019

News Daily News

Medicare Analysis Offers More Reassurances in Hullabaloo Over Paclitaxel-Based PAD Devices

L.A. McKeown

February 13, 2019

Presentation

DES vs DCB Revascularization in Patients With Femoropopliteal Arterial Disease

February 11, 2019

Podcast TCTMD Talking Points

ReCre8: A New Polymer-Free DES

February 06, 2019

Presentation ISET 2019

5-Year Results from the IN.PACT SFA Randomized Trial

Presenter: Gary Ansel

January 30, 2019

Presentation ISET 2019

Drug-Coated Therapy for ISR: Review of Options and Data

Presenter: Brian DeRubertis

January 30, 2019

Presentation ISET 2019

Current Options in the Management of Superficial Arterial Disease in 2019

Presenter: Gary Ansel

January 30, 2019

News Daily News

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

L.A. McKeown

January 25, 2019

Advertisement

ISCHEMIA Patients: High Rates of Severe-to-Moderate Ischemia, Multivessel CAD

The Case for Collateralization: CABG’s Mechanism for Survival in Stable CAD Underappreciated by Patients

FDA Approves Orsiro Ultrathin-Strut Stent for CAD

BIONYX: A Thin Composite-Wire Strut, Durable Polymer-Based DES Compared With an Ultrathin-Strut Bioresorbable Polymer-Based DES in an All-Comers Patient Population

Mortality Data ‘Inadvertently Omitted’ From IN.PACT Analysis of Paclitaxel-Coated Balloons

Iatrogenic aortocoronary dissection after routine PCI

Small Vessel PCI

Small Vessel Intervention - DES

Treatment of Small Vessels Made Easy With Drug Eluting Balloon

12 months results of First-In-Man study with coronary dedicated bifurcation cobalt-chromium sirolimus-eluting stent BiOSS LimC

Overall Experience of Abluminus DES in Real World and Dedicate Global Clinical Registry

Cre8™ EVO: Turning PCI challenges of DM patients into today’s solution

Unmet Clinical Needs With Current Drug-Eluting Stents

Medicare Analysis Offers More Reassurances in Hullabaloo Over Paclitaxel-Based PAD Devices

DES vs DCB Revascularization in Patients With Femoropopliteal Arterial Disease

ReCre8: A New Polymer-Free DES

5-Year Results from the IN.PACT SFA Randomized Trial

Drug-Coated Therapy for ISR: Review of Options and Data

Current Options in the Management of Superficial Arterial Disease in 2019

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content